Labiana Health, S.A. (BME:LAB)

Spain flag Spain · Delayed Price · Currency is EUR
3.600
0.00 (0.00%)
Last updated: Jun 17, 2025
41.73%
Market Cap 25.35M
Revenue (ttm) 67.37M
Net Income (ttm) 253.45K
Shares Out 7.04M
EPS (ttm) n/a
PE Ratio 100.00
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 495
Average Volume 1,929
Open 3.600
Previous Close 3.600
Day's Range 3.600 - 3.600
52-Week Range 1.860 - 3.600
Beta 0.17
RSI 67.08
Earnings Date n/a

About Labiana Health

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized, and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contract developments and manufacturing services. Labi... [Read more]

Sector Healthcare
Founded 1958
Employees 369
Stock Exchange Madrid Stock Exchange
Ticker Symbol LAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.